December 8, 2025Blood

Clinical outcomes and barriers of autologous hematopoietic stem cell transplantation in newly diagnosed high-risk multiple myeloma in a non-transplant center: Assessing the impact of transplant accessibility on racial minorities

View Full Paper

Ask AI

Bookmark

Authors

ATAbraham TitusUniversity of South Alabama LHL. A. HealeyUniversity of South Alabama DWDerek WerthmannTulane University

Discussion

Member takes

Implication

Retrospective analysis highlights inequitable access to autologous stem cell transplantation for high-risk multiple myeloma, suggesting novel therapeutic agents may improve outcomes.

Key Points

Evaluate the clinical outcomes and barriers to autologous hematopoietic stem cell transplantation in newly diagnosed high-risk multiple myeloma populations.
Conducted a retrospective chart review at a single academic institution
Analyzed clinical data for 57 patients diagnosed with high-risk multiple myeloma
Assessed the influence of socioeconomic factors on transplant accessibility
Patients who underwent autologous hematopoietic stem cell transplantation had longer time from diagnosis to follow-up (80.8 months) than those who did not (21.8 months)
Progression-free survival was longer for autoHSCT patients (50 months) compared to non-transplanted (20.5 months)
Overall survival was significantly longer in white patients (79.3 months) versus minority patients (23.6 months)

Cite This Study

Titus et al. (2025) studied this question.

synapsesocial.com/papers/69362f444fa91c937236d61e https://doi.org/10.1182/blood-2025-7601

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis highlights inequitable access to autologous stem cell transplantation for high-risk multiple myeloma, suggesting novel therapeutic agents may improve outcomes.

Clinical outcomes and barriers of autologous hematopoietic stem cell transplantation in newly diagnosed high-risk multiple myeloma in a non-transplant center: Assessing the impact of transplant accessibility on racial minorities

Discussion

Member takes

Implication

Key Points

Cite This Study

Clinical outcomes and barriers of autologous hematopoietic stem cell transplantation in newly diagnosed high-risk multiple myeloma in a non-transplant center: Assessing the impact of transplant accessibility on racial minorities

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider